Cynthia Collins

Cynthia Collins is a declared insider at 5 companies (board member); the most frequent names are Certara, Inc., Poseida Therapeutics, Inc. and DermTech, Inc. Over a trading history stretching from 26 May 2021 to 17 June 2026, the count stands at 17 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 22 June 2026: a share grant, in Maxcyte, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.